These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. An analysis of finder's fees in clinical research. Maher EA CMAJ; 1994 Jan; 150(2):252-6. PubMed ID: 8287347 [No Abstract] [Full Text] [Related]
24. Economic issues in defining stable funding levels for HIV/AIDS research. Eastaugh SR J Health Adm Educ; 1992; 10(1):139-49. PubMed ID: 10118035 [No Abstract] [Full Text] [Related]
25. Funding for clinical trials. Meinert CL Control Clin Trials; 1982 Sep; 3(3):165-71. PubMed ID: 6759031 [TBL] [Abstract][Full Text] [Related]
26. And the research continues... Wilensky GR Internist; 1985; 26(5):20, 22. PubMed ID: 10311172 [No Abstract] [Full Text] [Related]
27. Per diem rates and true costs: apples and oranges. Cork LC Comp Med; 2002 Feb; 52(1):10-1. PubMed ID: 11900408 [No Abstract] [Full Text] [Related]
28. Health policy report: the new era of prospective payment for hospitals. Iglehart JK N Engl J Med; 1982 Nov; 307(20):1288-92. PubMed ID: 6813735 [No Abstract] [Full Text] [Related]
30. Prospective payment and the university hospital. Bergen SS; Roth AC N Engl J Med; 1984 Feb; 310(5):316-8. PubMed ID: 6419109 [No Abstract] [Full Text] [Related]
31. ["Same procedure as every year?": Cost increase in Public Health]. Rosemann TA; Huber CA Praxis (Bern 1994); 2009 Dec; 98(25):1481-2. PubMed ID: 20112460 [No Abstract] [Full Text] [Related]
32. Who pays for clinical research? Weiss GB Clin Res; 1979 Oct; 27(4):297-9. PubMed ID: 10309043 [No Abstract] [Full Text] [Related]
33. Hospital reimbursement schemes. Japan's point system and the United States' diagnosis-related groups. Abe MA Med Care; 1985 Sep; 23(9):1055-66. PubMed ID: 3928986 [TBL] [Abstract][Full Text] [Related]
34. The Blues' blitz on health care costs. Demkovich LE Natl J (Wash); 1979 Jun; 11(22):902-6. PubMed ID: 10241583 [No Abstract] [Full Text] [Related]
36. [Research cooperation with industry from the viewpoint of surgery]. Pichlmayr R Langenbecks Arch Chir Suppl Kongressbd; 1997; 114():352-7. PubMed ID: 9574153 [No Abstract] [Full Text] [Related]
37. Estimating the cost of new drug development: is it really 802 million dollars? Adams CP; Brantner VV Health Aff (Millwood); 2006; 25(2):420-8. PubMed ID: 16522582 [TBL] [Abstract][Full Text] [Related]
38. Economic benefits of sponsored clinical trials on pharmaceutical expenditures at a medical center in Taiwan. Shen LJ; Chou H; Huang CF; Chou GM; Chan WK; Wu FL Contemp Clin Trials; 2011 Jul; 32(4):485-91. PubMed ID: 21530679 [TBL] [Abstract][Full Text] [Related]
39. A rational reimbursement plan. Segal EA Bus Health; 1983 Dec; 1(2):13-4. PubMed ID: 10310513 [No Abstract] [Full Text] [Related]